Poliovirus serological assay after the cVDPV1 outbreak in Papua New Guinea: a cross-sectional study from 2020 to 2021Research in context
Summary: Background: In June 2018, a type 1 circulating vaccine-derived poliovirus (cVDPV1) outbreak was declared in Papua New Guinea (PNG), resulting in a total of 26 paralytic confirmed cases. Eight vaccination campaign rounds with bivalent oral poliovirus vaccine (bOPV) were carried out in respon...
Saved in:
Main Authors: | William Pomat (Author), Rocio Lopez Cavestany (Author), Visalakshi Jeyaseelan (Author), Rebecca Ford (Author), Janet Gare (Author), Tigran Avagyan (Author), Varja Grabovac (Author), Deborah Bettels (Author), Dessie Mekonnen (Author), Kathryn Ann Vetter Jones (Author), Bernardo Alfredo Mainou (Author), Ondrej Mach (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Re-emergence of poliomyelitis in the Ukraine, caused by circulating vaccine-derived poliovirus type 2 (cVDPV2)
by: Damian Alexander Honeyman, et al.
Published: (2022) -
Effective partnership and in-country resource mobilization in Sudan for cVDPV2 outbreak response amid multiple emergencies in 2020-2021
by: Mohammed Taufiq Mashal, et al.
Published: (2024) -
Achieving high immunogenicity against poliovirus with fractional doses of inactivated poliovirus vaccine in Ecuador-results from a cross-sectional serological survey
by: Gabriel Trueba, et al.
Published: (2022) -
Achieving high seroprevalence against polioviruses in Sri Lanka-Results from a serological survey, 2014
by: Deepa Gamage, et al.
Published: (2015) -
Immunogenicity of two-dose and three-dose vaccination schedules with Sabin inactivated poliovirus vaccine in China: An open-label, randomized, controlled trial
by: Yamin Wang, et al.
Published: (2021)